drugset / Trial / NCT01785095

Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles

NCT01785095 ↗

Phase 3 Completed 41 enrolled IBSA Institut Biochimique SA
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate immunogenic potential of FSH-IBSA in healthy volunteers undergoing controlled ovarian hyperstimulation (COH) in an oocyte donation program.

Timeline

Start
2013-03
Primary completion
2014-07
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Follicle Stimulating Hormone Unknown — —

Indications

No indication recorded.